Health Disparities Meeting: Half Secret, Half Snooze
Published Date: 3/31/2025
Notice
Summary
The National Institute on Minority Health and Health Disparities is holding a hybrid meeting on May 6, 2025, open to the public for most of the day but closing later to review grant applications. This meeting affects researchers and organizations applying for funding, with some discussions kept private to protect personal and business info. You can join online or in person, and there’s a chance to send in your comments beforehand!
Analyzed Economic Effects
4 provisions identified: 3 benefits, 1 costs, 0 mixed.
Grant Reviews Held Privately
If you apply for a grant, the National Advisory Council will review grant applications in a closed session on May 6, 2025 from 4:05 p.m. to 5:30 p.m. The closed review is to protect confidential trade secrets, patentable material, and personal information tied to applications.
Open Session Videocast Available
You can watch the meeting open session by videocast at the NIH Videocast link on May 6, 2025 from 10:00 a.m. to 4:00 p.m. In-person attendance is allowed but limited to space available.
On‑Campus Security and ID Rules
If you plan to attend in person at NIH, you must follow NIH campus security rules: show one form of identification (for example, government photo ID, driver's license, or passport) and expect visitor vehicle inspections before entry.
Public May Submit Written Comments
Any interested person may file written comments with the committee by sending a statement to the listed Contact Person; the statement should include name, address, telephone number, and, if applicable, business or professional affiliation.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-05510, National Institute on Drug Abuse; Notice of Closed Meetings
The National Institute on Drug Abuse is holding a closed virtual meeting on May 7, 2025, to review grant applications for drug abuse research. This meeting keeps sensitive info private while deciding who gets funding to speed up important studies. Researchers applying for grants should note this key date as it impacts who gets support and when.
Next: 2025-05512, National Institute on Minority Health and Health Disparities; Notice of Partially Closed Meeting
The National Institute on Minority Health and Health Disparities is holding a hybrid meeting on May 5, 2025, where the public can join online or in person to hear updates and presentations. Later that day, a private session will review grant applications, protecting sensitive info. This meeting affects researchers and communities focused on minority health, with decisions that could impact funding and future projects.